UPDATE: Optimer Pharma (OPTR) Halted for Information (CBST)

(Updated - October 24, 2013 9:13 AM EDT) Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) trading halted for information. UPDATE - The following was made in an SEC 8-K filing after markets closed Wednesday: Optimer Pharmaceuticals, Inc., a Delaware corporation, held a special meeting of Optimer stockholders on October 23, 2013. At the Special Meeting, Optimer stockholders adopted the Agreement and Plan of Merger, dated as of July 30, 2013, among Optimer, Cubist Pharmaceuticals, Inc. (Nasdaq: CBST), and PDRS Corporation. Sufficient votes were received to adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if there were not sufficient votes to adopt the Merger Agreement, but an adjournment was not necessary in light of the adoption of the Merger Agreement. In addition, Optimer stockholders did not approve, by non-binding, advisory vote, certain compensation arrangements for Optimer’s named executive officers in connection with the merger contemplated by the Merger Agreement.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Business First Bancshares Inc. (BFST) to acquire Oakwood Bancshares
• HOOKIPA Pharma Inc. (HOOK) Announces Pivotal Phase 2/3 Trial Design for HB-200 plus Pembrolizumab
• Paramount Global (PARA) and Skydance are closer to a merger - CNBC